bioingenium

Its ability to combine the ease of manipulation found in bacterial systems with the protein folding capabilities of higher eukaryotic systems has made it a favored choice in the production of biopharmaceuticals. As a result, it continues to be a key player in the development and production of innovative biologics. The use of microbial expression systems, particularly bacterial expression systems, has revolutionized the field of biotechnology by providing a cost-effective and scalable method for producing proteins. Whether for therapeutic applications in the biopharmaceutical industry or for research purposes, these systems have proven to be versatile and efficient. Biopharmaceutical CDMOs, which often utilize these expression systems, play a critical role in the large-scale production of biologics, ensuring that new therapies reach patients quickly and safely.